NCT06068283Not yet recruiting
An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs
LOTUS: An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
The goal of this single arm pre-post study is to assess the feasibility, acceptability, and preliminary impact of the LOTUS intervention to improve HIV prevention service engagement among people who use drugs. LOTUS is a technology-delivered intervention that provides HIV prevention informational content and tips, peer social support and social networking features, a resource locator, HIV prevention monitoring and reminders (e.g., reminders for HIV/STI testing and PrEP doses), and a virtual space to have questions answered by health care professionals.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 19 Sept 2023
- Start date
- 1 Jul 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- University of California, San Diego
- Diseases
- HIV
- NCT number
- NCT06068283
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Jul 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Report high levels of HIV prevention service engagement in the past 6 months
Age
- 17 years of age or younger
Other
- Does not report weekly or daily use of opioids and/or stimulants in the past 6 months
- Does not meet current CDC eligibility criteria for PrEP
- Currently, or planning on becoming, pregnant during the study
- Does not own a smartphone with internet web-browsing capabilities
Who the study is looking for
- 18 years of age or older
- Report weekly or daily use of opioids and/or stimulants in the past 6 months
- Meet current CDC eligibility criteria for PrEP
- Report low levels of HIV prevention service engagement in the past 6 months
- Not currently, or planning on becoming, pregnant during the study
- Owns a smartphone with internet web-browsing capabilities
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.